Ticlopidine API Manufacturers

Looking for Ticlopidine API 55142-85-3?

Description:

Here you will find a list of producers, manufacturers and distributors of Ticlopidine. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.

API | Excipient name:

Ticlopidine 

Synonyms:

Ticlopidina , Ticlopidinum , Ticlopidine hydrochloride  

Cas Number:

55142-85-3 

DrugBank number:

DB00208 

Unique Ingredient Identifier:

OM90ZUW7M1

Ticlopidine is a type of Platelet Aggregation Inhibitors

Platelet Aggregation Inhibitors are a crucial category of pharmaceutical Active Pharmaceutical Ingredients (APIs) used in the field of cardiology and thrombosis management. These inhibitors play a vital role in preventing platelet aggregation, a process responsible for the formation of blood clots. By inhibiting platelet aggregation, these APIs reduce the risk of arterial thrombosis, which can lead to severe cardiovascular events like heart attacks and strokes.

Platelet Aggregation Inhibitors primarily work by targeting specific receptors on platelet cells, thereby impeding their activation and subsequent aggregation. The most commonly utilized APIs in this category include acetylsalicylic acid (aspirin), clopidogrel, ticagrelor, and prasugrel. These drugs are available in various forms, such as tablets, capsules, and intravenous formulations, allowing flexibility in their administration.

The effectiveness of Platelet Aggregation Inhibitors lies in their ability to prevent platelets from adhering to each other and forming clots within blood vessels. This property is especially crucial in patients with a high risk of cardiovascular events, such as those with a history of heart disease, diabetes, or peripheral artery disease.

While Platelet Aggregation Inhibitors are generally safe and effective, they can also carry potential side effects, including bleeding complications. Therefore, their administration requires careful consideration of individual patient characteristics and risk factors.

In conclusion, Platelet Aggregation Inhibitors represent a significant category of pharmaceutical APIs used for the prevention of platelet aggregation and subsequent blood clot formation. By inhibiting this process, they contribute to the management and reduction of cardiovascular events, offering critical benefits to patients at risk.

• Teva API from Israel, product country of origin Unknown
• Zhejiang Liaoyuan from China, product country of origin China
• Menovo from China, product country of origin China
• Humble Healthcaare from India, product country of origin India
• Rpg Life Sciences from India, product country of origin India
• S.I.M.S. from Italy, product country of origin Italy
• Euticals from Italy, product country of origin Unknown
• Sanofi from France, product country of origin Unknown
• Erregierre from Italy, product country of origin Italy
• Siegfried from Germany, product country of origin Unknown

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.